Elevance Health Inc (ELV) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ELV quarterly Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Elevance Health Inc funds operations, investments, and shareholder returns.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income5,661.00
Depreciation & amortization1,546.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-15.00
Asset Impairment Charges108.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation276.00
Income (Loss) from Equity Method Investments-398.00
Financial Instruments and Foreign Currency Transaction0.00
Net Losses Gains On Financial Instruments653.00
Income taxes-576.00
Increase (Decrease) in Trading Securities0.00
Increase (Decrease) in Receivables-2,526.00
Increase (Decrease) in Accounts Payable and Other Operating Liabilities-720.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital281.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities4,290.00
Investing Activities
Capital Expenditures-1,116.00
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities1,771.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Paymentstoacquireequitysecurities-
Proceedsfromsaleofequitysecurities-
Proceedsfromsaleofequityandfixedmaturitysecurities13,324.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-15,026.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired88.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-385.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1,344.00
Financing Activities
Short-term debt Net1,097.00
Other borrowing transactions386.00
Long-term debt - borrowings2,991.00
Long-term debt - repayments-2,147.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-2,526.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-10.00
Collareralpaymentsfordebtrelatedderivatives-
Payments For Proceeds From Financing Derivatives-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-1,529.00
Net Cash Flow from Financing Activities-1,738.00
Effect of exchange rate on cash flow-5.00
Discontinued operations0.00
Free Cash Flow3,174.00
Total Cash Flow1,203.00
4 historic quarters locked

Sign in to unlock the full Elevance Health Inc cash flow history.

About Elevance Health Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 6, 2026
  • Source: elv-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001156039-26-000013

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License